Literature DB >> 11087877

Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

J J Contos1, N Fukushima, J A Weiner, D Kaushal, J Chun.   

Abstract

Although extracellular application of lysophosphatidic acid (LPA) has been extensively documented to produce a variety of cellular responses through a family of specific G protein-coupled receptors, the in vivo organismal role of LPA signaling remains largely unknown. The first identified LPA receptor gene, lp(A1)/vzg-1/edg-2, was previously shown to have remarkably enriched embryonic expression in the cerebral cortex and dorsal olfactory bulb and postnatal expression in myelinating glia including Schwann cells. Here, we show that targeted deletion of lp(A1) results in approximately 50% neonatal lethality, impaired suckling in neonatal pups, and loss of LPA responsivity in embryonic cerebral cortical neuroblasts with survivors showing reduced size, craniofacial dysmorphism, and increased apoptosis in sciatic nerve Schwann cells. The suckling defect was responsible for the death among lp(A1)((-/-)) neonates and the stunted growth of survivors. Impaired suckling behavior was attributable to defective olfaction, which is likely related to developmental abnormalities in olfactory bulb and/or cerebral cortex. Our results provide evidence that endogenous lysophospholipid signaling requires an lp receptor gene and indicate that LPA signaling through the LP(A1) receptor is required for normal development of an inborn, neonatal behavior.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087877      PMCID: PMC27233          DOI: 10.1073/pnas.97.24.13384

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

Authors:  E J van Corven; A Groenink; K Jalink; T Eichholtz; W H Moolenaar
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

2.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.

Authors:  Z Guo; K Liliom; D J Fischer; I C Bathurst; L D Tomei; M C Kiefer; G Tigyi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel.

Authors:  L J Brunet; G H Gold; J Ngai
Journal:  Neuron       Date:  1996-10       Impact factor: 17.173

Review 5.  Recent advances in gene mutagenesis by site-directed recombination.

Authors:  J D Marth
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

6.  Nipple attachment and survival in neonatal olfactory bulbectomized rats.

Authors:  J M Risser; B M Slotnick
Journal:  Physiol Behav       Date:  1987

7.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

Authors:  T Eichholtz; K Jalink; I Fahrenfort; W H Moolenaar
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis.

Authors:  A Ghosh; M E Greenberg
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

9.  Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex.

Authors:  A J Blaschke; K Staley; J Chun
Journal:  Development       Date:  1996-04       Impact factor: 6.868

10.  Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.

Authors:  J H Hecht; J A Weiner; S R Post; J Chun
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

View more
  174 in total

1.  Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.

Authors:  Ryota Itoh; Shigenori Miura; Aki Takimoto; Shunya Kondo; Hiroko Sano; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

2.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis.

Authors:  Adrienne E Dubin; Deron R Herr; Jerold Chun
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 5.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 6.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 7.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

8.  Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors:  Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

9.  LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.

Authors:  Norihiko Sakai; Jerold Chun; Jeremy S Duffield; Takashi Wada; Andrew D Luster; Andrew M Tager
Journal:  FASEB J       Date:  2013-01-15       Impact factor: 5.191

Review 10.  Lysophosphatidic acid and renal fibrosis.

Authors:  Jean-Philippe Pradère; Julien Gonzalez; Julie Klein; Philippe Valet; Sandra Grès; David Salant; Jean-Loup Bascands; Jean-Sébastien Saulnier-Blache; Joost P Schanstra
Journal:  Biochim Biophys Acta       Date:  2008-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.